Bi Asset Management Fondsmaeglerselskab A Acadia Pharmaceuticals Inc Transaction History

Bi Asset Management Fondsmaeglerselskab A

  • $9.48 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$20.78 - $31.77 $66,205 - $101,219
3,186 New
3,186 $100,000
Q1 2020

May 11, 2020
SELL
$31.65 - $46.87 $437,687 - $648,165
-13,829 Closed
0 $0
Q4 2019

Mar 19, 2020
BUY
$36.21 - $51.4 $500,748 - $710,810
13,829 New
13,829 $592,000

Others Institutions Holding ACAD

# of Institutions
306
Shares Held
157M
Call Options Held
828K
Put Options Held
317K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $3.24B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Bi Asset Management Fondsmaeglerselskab A Portfolio

Follow Bi Asset Management Fondsmaeglerselskab A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bi Asset Management Fondsmaeglerselskab A, based on Form 13F filings with the SEC.

News

Stay updated on Bi Asset Management Fondsmaeglerselskab A with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email